Type 1 Diabetes Market: Market Segments: By Insulin Analog (Rapid-Acting Insulin Analogs, Long-Acting Insulin Analogs and Premix Insulin Analogs); By Drug Class (Insulin and Others); By Insulin Pumps (Insulin Pen, Blood Glucose Meters and Others); By Application (Children and Adults) and Region – Global Analysis of Market Size, Share & Trends for 2014– 2020 and Forecasts to 2030

Region:Global

Author(s):

Product Code:FG452

Download Sample Report download
Buy the Full ReportStarting from $5000
Published on

February 2021

Total pages

178

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $5000

About the Report

About the Report

Product Overview

Diabetes is a metabolic disease in which the pancreas is no longer able to secrete adequate insulin inside the pancreas. Diabetes is characterized by high blood glucose or high blood sugar level. Diabetes is primarily of 3 types-type 1, type 2, and diabetes. Type 1 diabetes is a medical condition in which the pancreas secretes less or no insulin. It occurs when the immune system destroys or attacks the insulin-making cells in the pancreas. These cells are known as beta cells. The other name of type 1 diabetes is juvenile diabetes as it is often diagnosed in children and young people. The symptoms of type 1 diabetes include increased thirst and hunger, frequent urination, stomach upset, fatigue, extreme weight loss, and late healing. Type 1 diabetes is treated with the help of insulin shots which control blood sugar levels.

Market Highlights

Global Type 1 Diabetes Market is expected to project a notable CAGR in 2030.

Global Type 1 Diabetes Market to surpass USD XXXX million by 2030 from USD XXXX million in 2019 at a CAGR of XX.X% in the coming years, i.e., 2020-30. Factors such as sedentary lifestyles, increasing prevalence of chronic diseases,unhealthy diet routine coupled with growing obesity rates are bolstering the market growth. The other factors contributing to the growth of the market include advancements in technology in diabetes treatment, increasing government initiatives and policies for type 1 diabetes, and rising patient awareness. 

Global Type 1 Diabetes Market: Segments

Rapid-Acting Insulin segment to grow with the highest CAGR during 2020-30

Global Type 1 Diabetes market is segmented by Insulin Analog into Rapid-Acting Insulin Analogs, Long-Acting Insulin Analogs, and Premix Insulin Analogs. Rapid-Acting Insulin, the segment held the largest market share of XX.X% in the year 2019 as they act very quickly to reduce the rise in blood sugar level which follows eating. Rapid-Acting Insulin is usually taken just before or with the meal. It can either be delivered or injected through an insulin pump.

Insulin segment to grow with the highest CAGR during 2020-30

Global Type 1 Diabetes market is divided by Drug Class into Insulin and Others. The insulin, the segment held the largest market share of XX.X% in the year 2019 and will continue to dominate the market in the coming years owing to the availability of various insulin delivery devices. The developments and technological advances in insulin delivery are propelling the growth of the segment.

Market Dynamics

Drivers

Technological advances in insulin delivery

Advent of several new classes of diabetics drugs and advancements in insulin delivery are the key factors propelling the market growth. The growing demand for minimally invasive and non-invasive insulin delivery is expected to spur market growth soon. The introduction of early insulin pumps and blood glucose meters, the development of new technologies, and the integration of consumer electronics and cloud-based data systems are likely to provide a strong impetus to market growth. Other factors that are driving the market growth include approval of insulin smartpens that records the timing and amount of insulin doses, with information exchanged with mobile apps to monitor patterns and make recommendations for dosing, developments in CGM and insulin pump technology, and the incorporation of CGM and insulin pumps into hybrid closed-loop systems that can change the delivery of insulin based on live glucose measurements.          

Increasing adoption of a sedentary lifestyle

The rising adoption of a sedentary lifestyle coupled with an unhealthy diet is resulting in the high growth of obesity and diabetes which is projected to have a positive impact on market growth. In urban and rural areas, the changing lifestyle has resulted in the increase in chronic diseases and unhealthy diet patterns among the children, which has led to rising in the number of children affected with type 1 diabetes.       

Restraint

High cost of treatment

Treatment therapies and diagnosis cost associated with diabetes is considerably high which can hinder the growth of type 1 diabetes market globally. Besides, unfavorable reimbursement policies are anticipated to inhibit the growth of the market in the coming years.

Global Type 1 Diabetes Market: Key Players

  •  Abbott Laboratories

Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis

  • Bayer AG
  • Eli Lilly and Company
  • GlaxoSmithKline
  • Johnson & Johnson Ltd
  • Merck & C0.
  • Pfizer Inc.
  • Takeda Pharmaceutical
  • AstraZeneca PLC.
  • XOMA Corp
  • Other Prominent Players

Global Type 1 Diabetes Market: Regions

Global Type 1 Diabetes Market is segmented based on regional analysis into five major regions. These include North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. global Type 1 Diabetes Market in North America held the largest market share of XX.X% in the year 2019. North America will continue to dominate the global Type 1 Diabetes market owing to rising healthcare expenditure, growing geriatric population, and changing lifestyle of people. In addition, several diabetes control and awareness initiatives organized by the government in the region is anticipated to further bolster the market growth. High adoption of technological advancements in the region is projected to support the market growth.

    Global Type 1 Diabetes Market is further segmented by region into:

  • North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United States and Canada
  • Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil, and Rest of Latin America
  • Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey, and Rest of Europe
  • Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia, and Rest of APAC
  • Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa, and Rest of MENA

Global Type 1 Diabetes Market report also contains analysis on:

Type 1 Diabetes Market Segments:

  • By Insulin Analog
    • Rapid-Acting Insulin Analogs
    • Long-Acting Insulin Analogs
    • Premix Insulin Analogs
  • By Drug Class
    • Insulin
    • Others
  • By Insulin Pumps
    • Insulin Pen
    • Blood Glucose Meters
    • Others
  • By Application
    • Children
    • Adults
  • Type 1 Diabetes Market Dynamics
  • Type 1 Diabetes Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies Involved in the Market
  • Value Chain of the Market
  • Market Drivers and Restraints

Products

Table of Contents

Table of Contents

Contents          

  1. Executive Summary
  2. Global Type 1 Diabetes Market
    1. Product Overview
    2. Market Definition
    3. Segmentation
    4. Assumptions and Acronyms
  3. Research Methodology
    1. Research Objectives
    2. Primary Research
    3. Secondary Research
    4. Forecast Model
    5. Market Size Estimation
  4. Average Pricing Analysis
  5. Macro-Economic Indicators
  6. Market Dynamics
    1. Growth Drivers
    2. Restraints
    3. Opportunity
    4. Trends
  7. Correlation & Regression Analysis
    1. Correlation Matrix
    2. Regression Matrix
  8. Recent Development, Policies & Regulatory Landscape
  9. Risk Analysis
    1. Demand Risk Analysis
    2. Supply Risk Analysis
  10. Global Type 1 Diabetes Market Analysis
    1. Porters Five Forces
      1. Threat of New Entrants
      2. Bargaining Power of Suppliers
      3. Threat of Substitutes
      4. Rivalry
    2. PEST Analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
  11. Global Type 1 Diabetes Market
    1. Market Size & forecast, 2020A-2030F
      1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12. Global Type 1 Diabetes Market: Market Segmentation
    1. By Regions
      1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of the Middle East and Africa), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    2. By Insulin Analog: Market Share (2020-2030F)
      1. Rapid-Acting Insulin Analogs, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Long-Acting Insulin Analogs, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3.  Premix Insulin Analogs, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    3. By Drug Class: Market Share (2020-2030F)
      1. Insulin, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    4. By Insulin Pumps: Market Share (2020-2030F)
      1. Insulin Pen, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Blood Glucose Meters, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030
    5. By Application: Market Share (2020-2030F)
      1. Children, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Adults, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F

Company Profile    

  1. Abbott Laboratories
    1. Company Overview
    2. Company Total Revenue (Financials)
    3. Market Potential
    4. Global Presence
    5. Key Performance Indicators
    6. SWOT Analysis
    7. Product Launch
  2. Bayer AG
  3. Eli Lilly and Company
  4. GlaxoSmithKline
  5. Johnson & Johnson Ltd.
  6. Merck & C0.
  7. Pfizer Inc.
  8. Takeda Pharmaceutical
  9. AstraZeneca PLC.
  10. XOMA Corp
  11. Other Prominent Players

Consultant Recommendation

**The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022